Similar Search Results

Strange bedfellows in the personal computer industry: technology alliances between IBM and Apple

Hagedoorn, John; Carayannis, Elias; Alexander, Jeffrey - In: Research Policy 30 (2001) 5, pp. 837-849

Persistent link: https://www.econbiz.de/10005372077

Mergers and acquisitions: Their effect on the innovative performance of companies in high-tech industries

Cloodt, Myriam; Hagedoorn, John; Van Kranenburg, Hans - In: Research Policy 35 (2006) 5, pp. 642-654

Persistent link: https://www.econbiz.de/10005372102

Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks

Roijakkers, Nadine; Hagedoorn, John - In: Research Policy 35 (2006) 3, pp. 431-446

Persistent link: https://www.econbiz.de/10005372186

Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology

Roijakkers, Nadine; Hagedoorn, John; van Kranenburg, Hans - In: Research Policy 34 (2005) 2, pp. 235-245

Persistent link: https://www.econbiz.de/10005372215

Inter-firm R&D partnerships: an overview of major trends and patterns since 1960

Hagedoorn, John - In: Research Policy 31 (2002) 4, pp. 477-492

Persistent link: https://www.econbiz.de/10005351290

Strategic technology partnering during the 1980s: Trends, networks and corporate patterns in non-core technologies

Hagedoorn, John - In: Research Policy 24 (1995) 2, pp. 207-231

Persistent link: https://www.econbiz.de/10005351488

Internationalization of corporate technology through strategic partnering: an empirical investigation

Duysters, Geert; Hagedoorn, John - In: Research Policy 25 (1996) 1, pp. 1-12

Persistent link: https://www.econbiz.de/10005351670

Is there complementarity or substitutability between internal and external R&D strategies?

Hagedoorn, John; Wang, Ning - In: Research Policy 41 (2012) 6, pp. 1072-1083

The various strands of extant empirical research are inconclusive about the complementarity or substitutability between different innovation mechanisms, such as internal and external R&D. Using a panel sample of 83 incumbent pharmaceutical firms covering the period 1986–2000, our empirical...

Persistent link: https://www.econbiz.de/10010869354

Measuring innovative performance: is there an advantage in using multiple indicators?

Hagedoorn, John; Cloodt, Myriam - In: Research Policy 32 (2003) 8, pp. 1365-1379

Persistent link: https://www.econbiz.de/10005461773

Partnerships in transition economies: international strategic technology alliances in Russia

Hagedoorn, John; Sedaitis, Judith B. - In: Research Policy 27 (1998) 2, pp. 177-185

Persistent link: https://www.econbiz.de/10005461786